within Pharmacolibrary.Drugs.ATC.C;

model C03BA04
  extends Pharmacokinetic.Models.PK_2C_enteral(
    weight         = 70,
    F              = 0.65,
    Cl             = 4.9999999999999996e-06,
    adminDuration  = 600,
    adminMass      = 50 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.018,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0010166666666666666,
    Tlag           = 1800,            
    Vdp             = 0.034,
    k12             = 0.47,
    k21             = 0.47
    
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>C03BA04</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Chlortalidone is a thiazide-like diuretic commonly used for the treatment of hypertension and edema associated with congestive heart failure, hepatic cirrhosis, and renal disorders. It acts by inhibiting sodium and chloride reabsorption in the distal convoluted tubule, leading to increased excretion of sodium, chloride, and water. Chlortalidone is approved and widely used today as an antihypertensive and diuretic agent.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetics described for healthy adult volunteers following oral administration.</p><h4>References</h4><ol><li><p>McCormack, PL, &amp; Wagstaff, AJ (2003). Lacidipine: a review of its use in the management of hypertension. <i>Drugs</i> 63(21) 2327–2356. DOI:<a href=\"https://doi.org/10.2165/00003495-200363210-00008\">10.2165/00003495-200363210-00008</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/14524737/\">https://pubmed.ncbi.nlm.nih.gov/14524737</a></p></li><li><p>Riva, E, et al., &amp; McAinsh, J (1980). Pharmacokinetics of atenolol in hypertensive subjects with and without co-administration of chlorthalidone. <i>European journal of clinical pharmacology</i> 17(5) 333–337. DOI:<a href=\"https://doi.org/10.1007/BF00558445\">10.1007/BF00558445</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/7418712/\">https://pubmed.ncbi.nlm.nih.gov/7418712</a></p></li><li><p>Porter, RH, et al., &amp; Suki, WN (1978). Treatment of hypoparathyroid patients with chlorthalidone. <i>The New England journal of medicine</i> 298(11) 577–581. DOI:<a href=\"https://doi.org/10.1056/NEJM197803162981101\">10.1056/NEJM197803162981101</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/628374/\">https://pubmed.ncbi.nlm.nih.gov/628374</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end C03BA04;
